Regulation of CD8+ T cell development by thymus-specific proteasomes. 2007

Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
Laboratory of Frontier Science, Core Technology and Research Center, Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo 113-8613, Japan. smurata@rinshoken.or.jp

Proteasomes are responsible for generating peptides presented by the class I major histocompatibility complex (MHC) molecules of the immune system. Here, we report the identification of a previously unrecognized catalytic subunit called beta5t. beta5t is expressed exclusively in cortical thymic epithelial cells, which are responsible for the positive selection of developing thymocytes. Although the chymotrypsin-like activity of proteasomes is considered to be important for the production of peptides with high affinities for MHC class I clefts, incorporation of beta5t into proteasomes in place of beta5 or beta5i selectively reduces this activity. We also found that beta5t-deficient mice displayed defective development of CD8(+) T cells in the thymus. Our results suggest a key role for beta5t in generating the MHC class I-restricted CD8(+) T cell repertoire during thymic selection.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013950 Thymus Gland A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat. Thymus,Gland, Thymus,Glands, Thymus,Thymus Glands
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
April 2002, The Journal of experimental medicine,
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
January 1999, Neuroimmunomodulation,
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
January 2000, Immunologic research,
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
October 2000, Seminars in immunology,
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
July 1996, Journal of theoretical biology,
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
May 2009, Cancer research,
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
November 2000, Science (New York, N.Y.),
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
March 2016, European journal of immunology,
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
October 2006, Infection and immunity,
Shigeo Murata, and Katsuhiro Sasaki, and Toshihiko Kishimoto, and Shin-Ichiro Niwa, and Hidemi Hayashi, and Yousuke Takahama, and Keiji Tanaka
February 2009, Seminars in immunology,
Copied contents to your clipboard!